$21.80
0.090.41%
At close: -
$21.80
0.000.00%
After Hours: Dec 20, 4:54 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Integra Lifesciences (IART) was reported on November 4, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $0.81 to $0.89, compared to the estimated EPS of $0.87. Additionally, Integra Lifesciences forecasted revenue between $0.44B and $0.45B for the quarter.
Browse guidance and forecast on all stocks.